Ogivri 440 mg (Trastuzumab POWDER FOR SOLUTION) 440 MG

OGIVRI 440 MG is a powder for solution used in intravenous therapy. It contains trastuzumab, a biosimilar medication for targeted treatment. This product is manufactured by Biosimilar Collaborations Ireland Limited.

Strength

440 MG

Pack Size

50ML VIAL

Manufacturer / TM Owner

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OGIVRI 440 MG is primarily used in the treatment of certain types of cancer, particularly those that involve the HER2 protein. It is often prescribed for breast cancer and gastric cancer. The medication works by targeting and blocking the action of the HER2 protein, which can help slow or stop the growth of cancer cells. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Side Effects

Common effects of OGIVRI 440 MG may include fatigue, nausea, and fever. Some patients may experience more severe side effects such as infusion reactions, which can include chills, fever, and difficulty breathing. It is important to monitor for any adverse reactions and report them to a healthcare professional immediately.

Precautions & Warnings

OGIVRI 440 MG should be handled with care and prepared by a healthcare professional. It is crucial to follow proper storage and administration guidelines to ensure safety. Patients with a history of heart problems or certain allergies should inform their healthcare provider before starting treatment. Always use this medication under the supervision of a qualified healthcare professional.

Avoid Interactions

OGIVRI 440 MG may interact with other medications, including those that affect the immune system or heart function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy and safety of this medication.

Frequently Asked Questions

OGIVRI 440 MG is used in the treatment of certain types of cancer, particularly those involving the HER2 protein, such as breast cancer and gastric cancer.

OGIVRI 440 MG is administered intravenously as a solution prepared from the powder.

Common side effects may include fatigue, nausea, fever, and infusion reactions such as chills and difficulty breathing.

Patients with a history of heart problems or certain allergies should consult their healthcare provider before taking OGIVRI 440 MG.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.